Join Cameron English and Dr. Chuck Dinerstein on Episode 127 of the Science Dispatch podcast as they discuss:
Nicotine vaping continues to outperform FDA-approved smoking cessation therapies in well-designed studies, including a new clinical trial conducted in Australia. This growing body of evidence badly undermines regulations that limit adult access to safer nicotine products that could save their lives.
Listen to the Science Dispatch on iTunes Spotify, Stitcher and Google Podcasts. Or add the RSS feed to your favorite podcast app. Join our Dispatch newsletter to get these stories and more delivered to your inbox.
